Search Results - "European journal of clinical pharmacology"

Refine Results
  1. 1

    Therapeutic drug monitoring of oral targeted antineoplastic drugs by Mueller-Schoell, Anna, Groenland, Stefanie L., Scherf-Clavel, Oliver, van Dyk, Madelé, Huisinga, Wilhelm, Michelet, Robin, Jaehde, Ulrich, Steeghs, Neeltje, Huitema, Alwin D.R., Kloft, Charlotte

    Published in European journal of clinical pharmacology (01-04-2021)
    “…Purpose This review provides an overview of the current challenges in oral targeted antineoplastic drug (OAD) dosing and outlines the unexploited value of…”
    Get full text
    Journal Article
  2. 2

    Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria by Motter, Fabiane Raquel, Fritzen, Janaína Soder, Hilmer, Sarah Nicole, Paniz, Érika Vieira, Paniz, Vera Maria Vieira

    Published in European journal of clinical pharmacology (01-06-2018)
    “…Purpose Potentially inappropriate medication (PIM) use causes preventable adverse drug reactions in older patients. Several assessment tools have been…”
    Get full text
    Journal Article
  3. 3

    Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis by Oscanoa, T. J., Lizaraso, F., Carvajal, Alfonso

    Published in European journal of clinical pharmacology (01-06-2017)
    “…Introduction It is currently admitted that adverse drug reactions (ADRs) account for a great burden of disease. Of particular concern are ADR-induced hospital…”
    Get full text
    Journal Article
  4. 4

    The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries by Renom-Guiteras, Anna, Meyer, Gabriele, Thürmann, Petra A.

    Published in European journal of clinical pharmacology (01-07-2015)
    “…Purpose The aim of the study was to develop a European list of potentially inappropriate medications (PIM) for older people, which can be used for the analysis…”
    Get full text
    Journal Article
  5. 5

    Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies by Ragia, Georgia, Manolopoulos, Vangelis G.

    Published in European journal of clinical pharmacology (01-12-2020)
    “…Aim The COVID-19 pandemic caused by infection with the novel coronavirus SARS-CoV-2 is urging the scientific community worldwide to intense efforts for…”
    Get full text
    Journal Article
  6. 6

    Proton pump inhibitor use: systematic review of global trends and practices by Shanika, Lelwala Guruge Thushani, Reynolds, Andrew, Pattison, Sharon, Braund, Rhiannon

    Published in European journal of clinical pharmacology (01-09-2023)
    “…Purpose Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While…”
    Get full text
    Journal Article
  7. 7

    Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review by Tommelein, Eline, Mehuys, Els, Petrovic, Mirko, Somers, Annemie, Colin, Pieter, Boussery, Koen

    Published in European Journal of Clinical Pharmacology (01-12-2015)
    “…Background Potentially inappropriate prescribing (PIP) is one of the main risk factors for adverse drug events (ADEs) in older people. Purpose This systematic…”
    Get full text
    Journal Article Book Review
  8. 8

    Clinical pharmacokinetics of melatonin: a systematic review by Harpsøe, Nathja Groth, Andersen, Lars Peter Holst, Gögenur, Ismail, Rosenberg, Jacob

    Published in European journal of clinical pharmacology (01-08-2015)
    “…Purpose The aim of the review was to provide an overview of studies investigating the pharmacokinetics of exogenous melatonin in humans and if possible, to…”
    Get full text
    Journal Article
  9. 9

    What about COVID-19 and arachidonic acid pathway? by Hoxha, Malvina

    Published in European journal of clinical pharmacology (01-11-2020)
    “…Background and objective COVID-19 is a highly contagious viral disease. In this study, we tried to define and discuss all the findings on the potential…”
    Get full text
    Journal Article
  10. 10

    A review on colistin nephrotoxicity by Ordooei Javan, Atefeh, Shokouhi, Shervin, Sahraei, Zahra

    Published in European journal of clinical pharmacology (01-07-2015)
    “…Purpose Colistin is an antibiotic that was introduced many years ago and was withdrawn because of its nephrotoxicity. Nowadays, reemergence of this antibiotic…”
    Get full text
    Journal Article
  11. 11

    Use of proton pump inhibitors in adults in France: a nationwide drug utilization study by Lassalle, Marion, Le Tri, Thien, Bardou, Marc, Biour, Michel, Kirchgesner, Julien, Rouby, Frank, Dumarcet, Nathalie, Zureik, Mahmoud, Dray-Spira, Rosemary

    Published in European journal of clinical pharmacology (01-03-2020)
    “…Purpose Proton pump inhibitor (PPI) drugs are approved for the management of gastric acid–related diseases, mainly treatment of gastroesophageal reflux…”
    Get full text
    Journal Article
  12. 12

    A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people by Reeve, Emily, Ong, Magdalene, Wu, Angela, Jansen, Jesse, Petrovic, Mirko, Gnjidic, Danijela

    Published in European journal of clinical pharmacology (01-08-2017)
    “…Purpose Benzodiazepines are effective medicines for insomnia and anxiety but are commonly used beyond recommended treatment time frames, which may lead to…”
    Get full text
    Journal Article
  13. 13

    Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review by Lisibach, Angela, Benelli, Valérie, Ceppi, Marco Giacomo, Waldner-Knogler, Karin, Csajka, Chantal, Lutters, Monika

    Published in European journal of clinical pharmacology (01-02-2021)
    “…Purpose Older people are at risk of anticholinergic side effects due to changes affecting drug elimination and higher sensitivity to drug’s side effects…”
    Get full text
    Journal Article
  14. 14

    Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers by Sheng, Xiao-yan, Liang, Yan, Yang, Xue-yuan, Li, Li-e, Ye, Xia, Zhao, Xia, Cui, Yi-min

    Published in European journal of clinical pharmacology (01-03-2020)
    “…Purpose The aim of the present study was to evaluate the safety, pharmacokinetic (PK) and pharmacodynamic (PD) properties of remimazolam besylate following…”
    Get full text
    Journal Article
  15. 15

    Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review by Sharifzadeh, Shiva, Mohammadpour, Amir Hooshang, Tavanaee, Ashraf, Elyasi, Sepideh

    Published in European journal of clinical pharmacology (01-03-2021)
    “…Background Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) is a delayed infrequent potentially life-threatening idiosyncratic drug…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis by Alzahrani, Abdulaziz S., Price, Malcolm J., Greenfield, Sheila M., Paudyal, Vibhu

    Published in European journal of clinical pharmacology (01-09-2021)
    “…Aim This study aimed to undertake a systematic review and meta-analysis of global prevalence and types of complementary and alternative medicine (CAM) use…”
    Get full text
    Journal Article
  18. 18

    Systematic review of anticholinergic risk scales in older adults by Durán, Carlos E., Azermai, Majda, Vander Stichele, Robert H.

    Published in European journal of clinical pharmacology (01-07-2013)
    “…Background Anticholinergic drugs are often involved in explicit criteria for inappropriate prescribing in older adults. Several scales were developed for…”
    Get full text
    Journal Article
  19. 19

    The nocebo effect challenges the non-medical infliximab switch in practice by Boone, N. W., Liu, L., Romberg-Camps, M. J., Duijsens, L., Houwen, C., van der Kuy, P. H. M., Janknegt, R., Peeters, R., Landewé, R. B. M., Winkens, B., van Bodegraven, A. A.

    Published in European journal of clinical pharmacology (01-05-2018)
    “…Background In clinical practice, non-medical switching of biological medication may provoke nocebo effects due to unexplained deterioration of therapeutic…”
    Get full text
    Journal Article
  20. 20

    Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis by Zheng, Wu Yi, Richardson, L. C., Li, L., Day, R. O., Westbrook, J. I., Baysari, M. T.

    “…Purpose Drug-drug interactions (DDIs) are often avoidable and, if undetected, can lead to patient harm. This review aimed to determine the prevalence of…”
    Get full text
    Journal Article